SAB Biotherapeutics Inc. (SABS)
NASDAQ: SABS · IEX Real-Time Price · USD
1.98
0.04 (2.06%)
May 27, 2022 4:00 PM EDT - Market closed
Ratios and Metrics (Annual)
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | Current | 2021 |
|---|---|---|
| Market Capitalization | 85 | 340 |
| Enterprise Value | 69 | 307 |
| PE Ratio | - | -19.80 |
| PS Ratio | - | 5.58 |
| PB Ratio | 2.06 | 8.81 |
| P/OCF Ratio | - | 90.34 |
| EV/Sales Ratio | - | 5.51 |
| Debt / Equity Ratio | 0.16 | 0.17 |
| Debt / EBITDA Ratio | - | -0.44 |
| Debt / FCF Ratio | - | -0.94 |
| Current Ratio | 1.98 | 1.96 |
| Asset Turnover | - | 0.90 |
| Return on Equity (ROE) | - | -44.20% |
| Return on Assets (ROA) | - | -25.20% |
| Return on Capital (ROIC) | - | -53.60% |
| Earnings Yield | - | -5.05% |
| FCF Yield | - | -2.12% |
| Buyback Yield / Dilution | - | -1.21% |
| Total Shareholder Return | - | -1.21% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).